|
1.
|
Denhardt DT and Noda M: Osteopontin
expression and function: role in bone remodeling. J Cell Biochem
Suppl. 30–31:92–102. 1998.PubMed/NCBI
|
|
2.
|
Denhardt DT and Guo X: Osteopontin: a
protein with diverse functions. FASEB J. 7:1475–1482.
1993.PubMed/NCBI
|
|
3.
|
Lund SA, Giachelli CM and Scatena M: The
role of osteopontin in inflammatory processes. J Cell Commun
Signal. 3:311–322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Patani N, Jouhra F, Jiang W and Mokbel K:
Osteopontin expression profiles predict pathological and clinical
outcome in breast cancer. Anticancer Res. 28:4105–4110.
2008.PubMed/NCBI
|
|
5.
|
Higashiyama M, Ito T, Tanaka E and Shimada
Y: Prognostic significance of osteopontin expression in human
gastric carcinoma. Ann Surg Oncol. 14:3419–3127. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Weber GF, Lett GS and Haubein NC:
Osteopontin is a marker for cancer aggressiveness and patient
survival. Br J Cancer. 103:861–869. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Korita PV, Wakai T, Shirai Y, Matsuda Y,
Sakata J, Cui X, Ajioka Y and Hatakeyama K: Overexpression of
osteopontin independently correlates with vascular invasion and
poor prognosis in patients with hepatocellular carcinoma. Hum
Pathol. 39:1777–1783. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Coppola D, Szabo M, Boulware D, Muraca P,
Alsarraj M, Chambers AF and Yeatman TJ: Correlation of osteopontin
protein expression and pathological stage across a wide variety of
tumor histologies. Clin Cancer Res. 10:184–190. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Agrawal D, Chen T, Irby R, Quackenbush J,
Chambers AF, Szabo M, Cantor A, Coppola D and Yeatman TJ:
Osteopontin identified as lead marker of colon cancer progression,
using pooled sample expression profiling. J Natl Cancer Inst.
94:513–521. 2002. View Article : Google Scholar
|
|
10.
|
Rohde F, Rimkus C, Friederichs J,
Rosenberg R, Marthen C, Doll D, Holzmann B, Siewert JR and Janssen
KP: Expression of osteopontin, a target gene of de-regulated Wnt
signaling, predicts survival in colon cancer. Int J Cancer.
21:1717–1723. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Allan AL, George R, Vantyghem SA, Lee MW,
Hodgson NC, Engel CJ, Holliday RL, Girvan DP, Scott LA, Postenka
CO, et al: Role of the integrin-binding protein osteopontin in
lymphatic metastasis of breast cancer. Am J Pathol. 169:233–246.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Carlinfante G, Vassiliou D, Svensson O,
Wendel M, Heinegård D and Andersson G: Differential expression of
osteopontin and bone sialoprotein in bone metastasis of breast and
prostate carcinoma. Clin Exp Metastasis. 20:437–444. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Irby RB, McCarthy SM and Yeatman TJ:
Osteopontin regulates multiple functions contributing to human
colon cancer development and progression. Clin Exp Metastasis.
21:515–523. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Wai PY and Kuo PC: Osteopontin: regulation
in tumor metastasis. Cancer Metastasis Rev. 27:103–118. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Leali D, Moroni E, Bussolino F and Presta
M: Osteopontin overexpression inhibits in vitro
re-endothelialization via integrin engagement. J Biol Chem.
282:19676–19684. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Anborgh PH, Mutrie JC, Tuck AB and
Chambers AF: Role of the metastasis-promoting protein osteopontin
in the tumour micro-environment. J Cell Mol Med. 14:2037–2044.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Hsu KH, Tsai HW, Lin PW, Hsu YS, Shan YS
and Lu PJ: Osteopontin expression is an independent adverse
prognostic factor in resectable gastrointestinal stromal tumor and
its interaction with CD44 promotes tumor proliferation. Ann Surg
Oncol. 17:3043–3052. 2010. View Article : Google Scholar
|
|
18.
|
Dai J, Peng L, Fan K, Wang H, Wei R, Ji G,
Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W and Guo Y:
Osteopontin induces angiogenesis through activation of PI3K/AKT and
ERK1/2 in endothelial cells. Oncogene. 28:3412–3422. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Fong YC, Liu SC, Huang CY, Li TM, Hsu SF,
Kao ST, Tsai FJ, Chen WC, Chen CY and Tang CH: Osteopontin
increases lung cancer cells migration via activation of the
alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway. Lung
Cancer. 64:263–270. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Tuck AB, Hota C and Chambers AF:
Osteopontin (OPN)-induced increase in human mammary epithelial cell
invasiveness is urokinase (uPA)-dependent. Breast Cancer Res Treat.
70:197–204. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Hijiya N, Setoguchi M, Matsuura K, Higuchi
Y, Akizuki S and Yamamoto S: Cloning and characterization of the
human osteopontin gene and its promoter. Biochem J. 303:255–262.
1994.PubMed/NCBI
|
|
22.
|
Morimoto I, Sasaki Y, Ishida S, Imai K and
Tokino T: Identification of the osteopontin gene as a direct target
of TP53. Genes Chromosomes Cancer. 33:270–278. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Cristaudo A, Foddis R, Bonotti A, Simonini
S, Vivaldi A, Guglielmi G, Ambrosino N, Canessa PA, Chella A,
Lucchi M, Mussi A and Mutti L: Comparison between plasma and serum
osteopontin levels: usefulness in diagnosis of epithelial malignant
pleural mesothelioma. Int J Biol Markers. 25:164–170. 2010.
|
|
24.
|
Sreekanthreddy P, Srinivasan H, Kumar DM,
Nijaguna MB, Sridevi S, Vrinda M, Arivazhagan A, Balasubramaniam A,
Hegde AS, Chandramouli BA, et al: Identification of potential serum
biomarkers of glioblastoma: serum osteopontin levels correlate with
poor prognosis. Cancer Epidemiol Biomarkers Prev. 19:1409–1422.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Isa S, Kawaguchi T, Teramukai S, Minato K,
Ohsaki Y, Shibata K, Yonei T, Hayashibara K, Fukushima M, Kawahara
M, Furuse K and Mack PC: Serum osteopontin levels are highly
prognostic for survival in advanced non-small cell lung cancer:
results from JMTO LC 0004. J Thorac Oncol. 4:1104–1110. 2009.
View Article : Google Scholar : PubMed/NCBI
|
